Tirzepatide Dose Steps: What Each One Is For and How to Tolerate It
The complete tirzepatide dosing schedule from 2.5 mg to 15 mg, why slow titration matters, how to handle a dose you have missed, and when to adjust for side effects.
By Ruth Calder, Enforcement Editor
Our methodology sets out how these guides get researched and kept current.
Looking for a provider? Our 2026 comparison of the leading GLP-1 telehealth sellers is a click away.
Best Tirzepatide Providers →Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Tirzepatide's dose ladder is the foundation of how it works and how well it's tolerated. Starting at 2.5 mg, you spend at least 4 weeks on each level before moving up. The bottom rungs are not idle: in a real-world study of adults without diabetes, 2.5 mg then 5 mg took off 7.3% of body weight in twelve weeks. Each step buys more expected weight loss, and each step skipped very nearly guarantees GI side effects you cannot manage. Below is the week-by-week schedule for both Zepbound (weight management) and Mounjaro (diabetes), with the rationale for slow titration, what to do when you miss a dose, and when to deviate from the schedule.
If you're trying to decide between tirzepatide and semaglutide before starting, read semaglutide vs tirzepatide first. If you already have a prescription and need a provider, see our best tirzepatide providers ranking.
Key Takeaways
- Begin at 2.5 mg weekly and stay there a minimum of 4 weeks. The starting dose is for acclimation, not for weight loss.
- Six levels in all, starting at 2.5 mg and climbing through 5, 7.5, 10 and 12.5 to 15 mg, with a minimum of 4 weeks on each before moving up.
- Maintenance is 5, 10 or 15 mg, on Zepbound and Mounjaro alike.
- Maximum dose is 15 mg/week. This produced the strongest weight loss in SURMOUNT-1.
- Missed a dose? Take it within 4 days of the scheduled day. Skip it if more than 4 days have passed.
- Slow titration is the single most important tool for managing GI side effects.
The Full Dose Ladder
Both Zepbound and Mounjaro follow the same titration schedule. The FDA labels are nearly identical on dosing.
| Phase | Weeks | Dose | Purpose |
|---|---|---|---|
| Starting | 1–4 | 2.5 mg weekly | Acclimation (not treatment) |
| First step-up | 5–8 | 5 mg weekly | First maintenance option |
| Second step-up | 9–12 | 7.5 mg weekly | Bridge to higher dose |
| Third step-up | 13–16 | 10 mg weekly | Second maintenance option |
| Fourth step-up | 17–20 | 12.5 mg weekly | Bridge to highest dose |
| Maintenance | 21+ | 15 mg weekly | Maximum, highest weight loss |
The FDA label specifies that each dose must be maintained for at least 4 weeks before increasing. Some patients benefit from 6–8 weeks at a dose to allow side effects to fully subside before moving up.
Why Each Dose Level Exists
2.5 mg: Acclimation Dose
The 2.5 mg starting dose is not intended to produce significant weight loss. Its entire purpose is to let your GI tract adapt to slowed gastric motility before you hit a real treatment dose. Expect minimal weight change in the first 4 weeks. Many patients panic at this stage and assume the drug isn't working. It is; you're just on the acclimation dose.
5 mg: First Real Treatment Dose
At 5 mg, you enter the therapeutic range. SURMOUNT-1 showed mean weight loss of ~15% at the 5 mg dose after 72 weeks, already competitive with semaglutide's maximum dose. Many patients find 5 mg is enough, especially if side effects are well controlled.
7.5 mg: Bridge Dose
7.5 mg is the intermediate step between 5 mg and 10 mg. It isn't considered a maintenance dose in the FDA label, but patients can stay at 7.5 mg indefinitely if it's producing good results. The main reason to move past 7.5 mg is either plateau or the desire for more weight loss.
10 mg: Second Maintenance Dose
In SURMOUNT-1, 10 mg tirzepatide produced mean weight loss of ~19.5%. For most patients, 10 mg is the practical "sweet spot," with strong weight loss and manageable side effects. Many patients stop titrating here.
12.5 mg: Bridge to Maximum
12.5 mg is another bridge dose and rarely a long-term maintenance dose: most patients either stay at 10 mg or continue to 15 mg.
15 mg: Maximum Dose
15 mg tirzepatide is the highest FDA-approved dose and produced ~20.9% mean weight loss in SURMOUNT-1. This is the dose for patients who want maximum efficacy and can tolerate the side effects. Titration to 15 mg should only happen after at least 4 weeks at 12.5 mg (meaning you can't reach 15 mg until roughly week 21 at the earliest).
Why Slow Titration Matters
There is a reason for the FDA's 4-weeks-per-dose minimum. Tirzepatide's mechanism (slowed gastric emptying plus hypothalamic appetite suppression) depends on a steady-state blood level that takes about 4 weeks to establish at each new dose. Increasing before the body adapts to the prior dose stacks side effects:
- Nausea becomes persistent instead of transient
- Constipation can become severe enough to require medical intervention
- Dehydration compounds as reduced fluid intake meets slowed GI transit
- Early discontinuation is far more likely
In SURMOUNT-1, where patients titrated on the label schedule, adverse events led 4.3% to 7.1% of tirzepatide patients to stop treatment, depending on dose, against 2.6% on placebo.
For side-effect management at each dose level, most of the tactics in our semaglutide side effects guide apply to tirzepatide too.
What If Side Effects Are Too Much?
The FDA label allows several adjustments:
- Stay at your current dose longer. If you're at 5 mg and nausea hasn't resolved by week 8, don't increase. Hold at 5 mg for another 4 weeks and reassess.
- Drop back one dose level. If increasing from 7.5 mg to 10 mg causes severe GI symptoms, go back to 7.5 mg for 4–8 weeks before trying again.
- Pause the drug temporarily. If symptoms become severe (intractable vomiting, signs of dehydration, severe abdominal pain), your prescriber may pause tirzepatide and restart at a lower dose after symptoms resolve.
- Stop at your effective dose. There's no requirement to reach 15 mg. If you're losing weight steadily at 10 mg and tolerating it well, 10 mg is a valid long-term maintenance dose.
Missing a Dose
Per the FDA labels for Zepbound and Mounjaro:
- Still inside 4 days of the scheduled day: inject as soon as you remember, then go back to your usual weekly day.
- Past 4 days: let that dose go, and take the next one on your usual day.
- Never put two doses within 3 days of one another.
The labels don't address a longer gap. If you have missed several weekly doses in a row, talk to your prescriber, because titration may have to restart lower.
Switching the Day of the Week
You can change your injection day, but only if at least 3 days have passed since your last dose. The FDA label explicitly permits this. In practice, most patients pick a day that works with their schedule (often Sunday, to allow 24–48 hours of potential nausea before the work week) and stick with it.
Comparing Tirzepatide and Semaglutide Titration
| Drug | Starting dose | Step increments | Max dose | Typical time to max |
|---|---|---|---|---|
| Tirzepatide | 2.5 mg | 2.5 mg every 4 wks | 15 mg | ~20 weeks |
| Semaglutide | 0.25 mg | Variable | 2.4 mg (7.2 mg for Wegovy) | ~16 weeks to 2.4 mg |
Tirzepatide's ladder has six levels in even 2.5 mg steps. Wegovy's has five up to the usual 2.4 mg maintenance dose, and its label now adds a 7.2 mg option for adults who need more weight reduction. See our semaglutide dosing schedule for the parallel guide.
Pros and Cons of Tirzepatide Dosing
Pros of the tirzepatide dose schedule:
- Granular steps allow for finer side-effect management
- Multiple valid maintenance doses (5, 10, 15 mg)
- Flexibility to hold or step back if needed
- Among the largest mean weight losses of any approved drug (20.9% on 15 mg in SURMOUNT-1)
Cons of the tirzepatide dose schedule:
- Longer time to reach maximum efficacy (20+ weeks)
- More injection supplies needed through titration
- Patients can feel frustrated during the early "acclimation" weeks
- Each dose level increase can reset side effects
What the ladder costs depends on the seller. Better U Care, tru Weight Loss and Sumbare Wellness charge one compounded tirzepatide price at every dose. Alan Meds, Aspen and VevaRx do too, on plans of different lengths. So does LovelyMeds, which adds B12 to both of its formulas.
At Luma Health Co and Blis MD the price rises with the dose, so the later months cost more than the starting one.
A Typical Patient's First 6 Months
Here's a rough weight-loss trajectory. SURMOUNT-1 did not publish month-by-month figures, so treat these ranges as estimates:
| Month | Dose | Mean weight loss |
|---|---|---|
| 1 | 2.5 mg | 1–2% |
| 2 | 5 mg | 3–5% |
| 3 | 7.5 mg | 5–8% |
| 4 | 10 mg | 8–11% |
| 5 | 12.5 mg | 10–13% |
| 6 | 15 mg | 12–15% |
By the end of SURMOUNT-1 (72 weeks), mean weight loss on 15 mg was 20.9%. Individual results vary significantly.
Bottom Line
Tirzepatide dosing tests the patient's endurance as much as the pharmacology. SURMOUNT-1 showed unambiguously that the drug works, but the titration is long, the acclimation dose feels ineffective, and side effects can be frustrating. Three things matter above the rest: hold each dose the full 4 weeks, tell your prescriber how you are tolerating it, and leave the maximum alone unless your goals call for it.
For most patients, 10 mg is the practical sweet spot: strong weight loss, manageable side effects, and a dose level that's easy to stay at indefinitely. If you need to find a provider or switch to one offering better support during titration, check our best tirzepatide providers ranking. For the brand-name specifics on whether to take Mounjaro or Zepbound, see Mounjaro vs Zepbound.
Sources & methodology — as of September 2026
- 1.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 2.SURPASS-2 Trial — Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (Frías JP et al.)— New England Journal of Medicine.PMID: 34170647.
- 3.SURPASS-3 Trial — Tirzepatide versus Insulin Degludec in Type 2 Diabetes (Ludvik B et al.)— The Lancet.PMID: 34370970.
- 4.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Compare the sellers
Ready to compare GLP-1 providers?
Trust, support, availability, the medications carried and what they cost — we rank every major telehealth seller on all five, and refresh it each quarter. Nothing padded.
Best Tirzepatide Providers →Related guides
Semaglutide Dose Steps: What Each One Feels Like and How to Tolerate It
Week-by-week semaglutide titration chart, what to expect at each dose, side effect timing, and when to ask your prescriber to slow down or hold steady.
Mounjaro vs Zepbound Cost: Which One Insurance Pays For
Mounjaro and Zepbound are both tirzepatide with different FDA approvals. We compare indication, price and insurance coverage, and which one fits you.
How to Manage Semaglutide Side Effects, From Nausea to Constipation
A sourced guide to semaglutide side effects (nausea, constipation, fatigue, gallbladder, pancreatitis), with practical management steps and red flags.
Read our methodology · affiliate disclosure · about us